Yanghao Chen Selected Research

tabersonine

8/2022

Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanghao Chen Research Topics

Disease

2	Inflammation (Inflammations) 08/2022 - 06/2022
2	Fibrosis (Cirrhosis) 08/2022 - 06/2022
1	Heart Failure 08/2022
1	Obesity 06/2022
1	Hypertrophy 06/2022
1	Cardiomyopathies (Cardiomyopathy) 06/2022
1	Atherosclerotic Plaque (Atheroma) 05/2022
1	Atherosclerosis 05/2022
1	Choroidal Effusions 01/2022
1	Retinal Detachment (Retinal Detachments) 01/2022
1	Hepatic Encephalopathy 05/2021
1	Sepsis (Septicemia) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Lens Subluxation 07/2020
1	Aphakia 07/2020

Drug/Important Bio-Agent (IBA)

1	Angiotensin IIIBA 08/2022
1	p38 Mitogen-Activated Protein KinasesIBA 08/2022
1	tabersonineIBA 08/2022
1	Therapeutic UsesIBA 06/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 06/2022
1	Pharmaceutical PreparationsIBA 06/2022
1	bicyclolIBA 06/2022
1	Proteins (Proteins, Gene)FDA Link 06/2022
1	Apolipoproteins E (ApoE)IBA 05/2022
1	3-n-butylphthalide (butylphthalide)IBA 05/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	InflammasomesIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021

Therapy/Procedure

1	Stents 05/2021
1	Vitrectomy 07/2020